ArticleJournal of chemical information and modeling2026
Contact-Network Phenotyping of the CDK Family Reveals Selective Distal C-Lobe Contact Redistribution by Modern CDK5 Inhibitors and a Quantitative Selectivity Landscape against CDK2 and CDK1.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selective inhibition of CDK5 over CDK1, CDK2, CDK4, and CDK6 remains a central medicinal-chemistry challenge because pocket-centric methods capture local similarity but not full-domain structural phenotypes. Here we introduce kinase-aware contact-network phenotyping, a calculation-light approach that combines systematic Cα contact-map comparison with automated kinase topology annotation across 30 curated CDK crystal structures spanning CDK1, CDK2, CDK3, CDK4, CD5, and CD6 with 21 pairwise comparisons. Three findings emerge. First, the apo CDK5 to selective inhibitor transition (1H4L to 7VDP) produces 33.3% ligand-adjacent gained contacts (13 of 39), compared with 2.8% (1 of 36) for the apo to nonselective transition (1H4L to 1UNL); the apo-anchored ratio of 11.9-fold quantifies the selective-specific reorganization while controlling for generic pocket-occupancy effects, with the largest distance shifts (up to 14.6 Å) concentrated in the distal C-lobe core (residues 221 to 292). Second, the DFG aspartate D144 has the most atypical contact environment in CDK5 by the Miyazawa-Jernigan knowledge-based statistical-potential
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.